Phase
Condition
Systemic Candidiasis
Sexually Transmitted Diseases (Stds)
Vaginitis
Treatment
Hologic Aptima BV Assay
Cepheid Xpert Xpress MVP
BD Max™ Vaginal Panel
Clinical Study ID
Ages > 14 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Inclusion Criteria for Symptomatic Participants:
Symptomatic participants with a clinical presentation consistent with vaginitis,vaginosis, or both; symptoms may include abnormal vaginal discharge, painful orfrequent urination, vaginal itching or burning or irritation, painful oruncomfortable intercourse, and/or abnormal vaginal odor.
Participants aged 14 years or older who are willing and able to provide written,informed consent; for pediatric participants, written assent and parent/legalguardian consent, as applicable by the institutional review board/ethics committee (IRB/EC).
Inclusion Criteria for Asymptomatic Participants:
- Apparently healthy participants aged 14 years or older who are willing and able toprovide written, informed consent; for pediatric participants, written assent andparent/legal guardian consent, as applicable by the IRB/EC.
Exclusion
Exclusion Criteria:
Exclusion Criteria for Symptomatic Participants:
Participants not meeting the above described inclusion criteria will be excludedfrom the study.
Use of any azole-containing antimicrobial (oral or vaginal) within the 7 days priorto study enrollment.
Prior enrollment in this study.
Use of any lubricants (eg, Replens, RepHresh) within 3 days prior to samplecollection
Use of douches, vaginal deodorizers, or other intravaginal products within 3 daysprior to sample collection. The use of tampons or pads during menses should not beconsidered exclusionary criteria.
Contraindication to vaginal swab sampling.
Asymptomatic participants who do not have any signs or symptoms consistent withvaginitis, vaginosis, or both, as described above.
Exclusion Criteria for Asymptomatic Participants:
Prior enrollment in this study.
Participants with a clinical presentation consistent with vaginitis, vaginosis, orboth; symptoms may include abnormal vaginal discharge, painful or frequenturination, vaginal itching or burning or irritation, painful or uncomfortableintercourse, and/or abnormal vaginal odor.
Study Design
Connect with a study center
Diagnostic Consultative Center "Ascendent" Ltd.
Sofia, 1202
BulgariaSite Not Available
Centre Hospitalier Universitaire Vaudois (Chuv)
Lausanne, 1011
SwitzerlandSite Not Available
Matrix Clinical Research
Los Angeles, California 90057-4103
United StatesActive - Recruiting
M3 Wake Research - San Diego at Convoy
San Diego, California 92111
United StatesActive - Recruiting
Red Rocks OBGYN
Lakewood, Colorado 80228
United StatesCompleted
Altus Research
Lake Worth, Florida 33461
United StatesActive - Recruiting
Washington University
Saint Louis, Missouri 63110
United StatesActive - Recruiting
Eastern Carolina Women's Center
New Bern, North Carolina 28562
United StatesActive - Recruiting
Unified Women's Clinical Research/Lyndhurst
Winston-Salem, North Carolina 27103
United StatesActive - Recruiting
Planned Parenthood Gulf Coast
Houston, Texas 77023
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.